164 related articles for article (PubMed ID: 31841478)
1. PROGNOSIS OF THE COURSE OF CHORNOBYL-ORIGINATED ACUTE LYMPHOBLASTIC LEUKEMIA IN CHILDREN IN UKRAINE DEPENDING ON THE REASON OF STANDARD CHEMOTHERAPY INTERRUPTION.
Bebeshko VG; Bruslova KM; Tsvetkova NM; Lyashenko LO; Pushkariova TI; Gonchar LO; Tryhlib IV; Yatsemirskyi SM; Samson YM; Boyarskyi VG; Grischenko KV; Polyanska VM; Dmytrenko IV
Probl Radiac Med Radiobiol; 2019 Dec; 24():335-349. PubMed ID: 31841478
[TBL] [Abstract][Full Text] [Related]
2. PROGNOSIS OF ACUTE LEUKEMIA DEPENDING ON THE IRON METABOLISM PARAMETERS IN CHILDREN AFTER CHORNOBYL NUCLEAR POWER PLANT ACCIDENT.
Bebeshko VG; Bruslova KM; Lyashenko LO; Tsvietkova NM; Gonchar LO; Galkina SG; Zaitseva AL; Reznikova LS; Iatsemyrskii SM; Tsvet LO
Probl Radiac Med Radiobiol; 2020 Dec; 25():390-401. PubMed ID: 33361849
[TBL] [Abstract][Full Text] [Related]
3. State of erythroid, granulocyte and platelet branches of hematopoiesis on stages of chemotherapy in children with acute lymphoblastic leukemia, who were exposed to ionizing radiation after the Chornobyl NPP accident.
Bebeshko VG; Bruslova KM; Pushkareva TI; Tsvyetkova NM; Lyashenko LO; Kuznyetsova OY; Kuzmenko VF; Gonchar LO; Yaatsemyrskyy SM
Probl Radiac Med Radiobiol; 2016 Dec; 21():178-190. PubMed ID: 28027552
[TBL] [Abstract][Full Text] [Related]
4. Cortisol level as risk factor for malignant hematologic pathology in children exposed to ionizing radiation after Chornobyl accident.
Bebeshko VG; Bruslova KM; Pushkareva TI; Tsvietkova NM; Lyashenko LO; Sergeeva AS; Kuzmenko VF; Iatsemyrskiy SM; Samson YM; Boyarsky VG; Tryhlіb IV
Probl Radiac Med Radiobiol; 2017 Dec; 22():306-315. PubMed ID: 29286515
[TBL] [Abstract][Full Text] [Related]
5. EFFECT OF SOMEUNFAVORABLE FACTORS OF ENVIRONMENT ON THE SURVIVAL OF CHILDREN WITH ACUTE LEUKEMIA IN A LONG6TERM PERIOD AFTER ACCIDENT ON THE CHORNOBYL NPP.
Bebeshko VG; Bruslova KM; Tsvietkova NM; Lyashenko LO; Pushkareva TI; Honchar LO; Sergeeva AS; Yatsemyrskii M; Samson YM; Trihlib IV; Makovey OI
Probl Radiac Med Radiobiol; 2018 Dec; 23():254-262. PubMed ID: 30582851
[TBL] [Abstract][Full Text] [Related]
6. EFFICIENCY OF BONE MARROW PRECURSOR CELL COLONY-FORMING AS A PREDICTOR OF DISEASE COURSE IN PLASMA CELL MYELOMA PATIENTS WITH A HISTORY OF RADIATION EXPOSURE.
Minchenko ZM; Liubarets TF; Balan VV; Dmytrenko OO; Shlyakhtichenko TY; Moyseyenko VO; Silayev YO; Bebeshko VG
Probl Radiac Med Radiobiol; 2020 Dec; 25():490-501. PubMed ID: 33361856
[TBL] [Abstract][Full Text] [Related]
7. [Concept and interim result of the ALL-BFM 90 therapy study in treatment of acute lymphoblastic leukemia in children and adolescents: the significance of initial therapy response in blood and bone marrow].
Schrappe M; Reiter A; Sauter S; Ludwig WD; Wörmann B; Harbott J; Bender-Götze C; Dörffel W; Dopfer R; Frey E
Klin Padiatr; 1994; 206(4):208-21. PubMed ID: 7526027
[TBL] [Abstract][Full Text] [Related]
8. ENDOCRINE REGULATION OF ERYTHROID LINEAGE OF HEMATOPOIESIS IN CHILDREN LIVING UNDER A LOW-DOSE RADIATION EXPOSURE AFTER THE CHORNOBYL NPP ACCIDENT.
Bebeshko VG; Bruslova KM; Boyarska OY; Lyashenko LO; Tsvyetkova NM; Gonchar LO; Chernysh TO; Trychlib IV; Pismenniy VD; Yaroshenko ZS; Vasylenko VV
Probl Radiac Med Radiobiol; 2020 Dec; 25():374-389. PubMed ID: 33361848
[TBL] [Abstract][Full Text] [Related]
9. CHRONIC MYELOID LEUKEMIA COURSE IN PERSONS EXPOSED TO IONIZING RADIATION AS A RESULT OF THE CHORNOBYL ACCIDENT.
Dyagil IS; Dmytrenko IV; Sholoiko VV; Fedorenko VG; Shlyakhtichenko TY; Petrusha OO; Martina ZV; Tovstogan AO; Silayev YO; Stupakova ZV; Minchenko ZM
Probl Radiac Med Radiobiol; 2020 Dec; 25():443-455. PubMed ID: 33361853
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of median survival patients with acute lymphoblastic leukemia exposed to ionizing radiation by the Chornobyl accident, depending on the aminoacid composition of stromal fibroblasts bone marrow and indicators of myelogram.
Bebeshko VG; Bruslova KM; Tsvyetkova NM; Volodina TT; Pushkarova TI; Lyashenko LO; Panchenko LM; Iatsemirskii SM
Probl Radiac Med Radiobiol; 2015 Dec; 20():311-8. PubMed ID: 26695910
[TBL] [Abstract][Full Text] [Related]
11. ASSESSMENT OF QUALITATIVE CHANGES IN PERIPHERAL BLOOD CELLS IN CHILDREN - RESIDENTS OF RADIOLOGICALLY CONTAMINATED TERRITORIES IN THE LATE PERIOD AFTER THE ChNPP ACCIDENT.
Bebeshko VG; Bruslova KM; Lyashenko LO; Pushkariova TI; Tsvetkova NM; Galkina SG; Vasylenko VV; Yaroshenko ZS; Zaitseva AL; Gonchar LO; Yatsemirskyi SM
Probl Radiac Med Radiobiol; 2021 Dec; 26():297-308. PubMed ID: 34965556
[TBL] [Abstract][Full Text] [Related]
12. Effects of the in vivo administration of recombinant human granulocyte colony-stimulating factor following cytotoxic chemotherapy on granulocytic precursors in patients with malignant lymphoma.
Ema H; Suda T; Sakamoto S; Tomonaga T; Tsunoda J; Muroi K; Komatsu N; Miwa A; Ohsaka A; Yoshida M
Jpn J Cancer Res; 1989 Jun; 80(6):577-82. PubMed ID: 2474526
[TBL] [Abstract][Full Text] [Related]
13. [Granulocytopoiesis in acute lymphoblastic leukemia in children].
Vladimirskaia EB; Shershneva NS; Zamaraeva NV; Al Hasan S; Chukanin SN
Ter Arkh; 1988; 60(5):29-33. PubMed ID: 3175924
[TBL] [Abstract][Full Text] [Related]
14. Blast Percentage of Bone Marrow Aspirate on Day 14 of Induction Chemotherapy Predicts Adult Acute Lymphoblastic Leukemia Treatment Outcomes.
Park HS; Kim DY; Choi EJ; Lee JH; Lee JH; Jeon M; Kang YA; Lee YS; Seol M; Cho YU; Jang S; Chi HS; Lee KH; Park CJ
Acta Haematol; 2018; 139(4):220-227. PubMed ID: 29860259
[TBL] [Abstract][Full Text] [Related]
15. Granulocyte colony-stimulating factor (G-CSF) as an adjunct to induction chemotherapy of adult acute lymphoblastic leukemia (ALL).
Scherrer R; Geissler K; Kyrle PA; Gisslinger H; Jäger U; Bettelheim P; Laczika K; Locker G; Scholten C; Sillaber C
Ann Hematol; 1993 Jun; 66(6):283-9. PubMed ID: 7686404
[TBL] [Abstract][Full Text] [Related]
16. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
[TBL] [Abstract][Full Text] [Related]
17. [Treatment outcome of childhood standard-risk and median-risk acute lymphoblastic leukemia with CCLG-2008 protocol].
Liu X; Zou Y; Wang H; Chen X; Ruan M; Chen Y; Yang W; Guo Y; Liu T; Zhang L; Wang S; Zhang J; Liu F; Cai X; Qi B; Chang L; Zhu X
Zhonghua Er Ke Za Zhi; 2014 Jun; 52(6):449-54. PubMed ID: 25190166
[TBL] [Abstract][Full Text] [Related]
18. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
19. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
[TBL] [Abstract][Full Text] [Related]
20. The dose related effect of steroids on blast reduction rate and event free survival in children with acute lymphoblastic leukemia.
Yetgin S; Cetin M
Leuk Lymphoma; 2003 Mar; 44(3):489-95. PubMed ID: 12688320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
